DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award

General Information Document Type: Grants Notice Funding Opportunity Number: HT942526DMDRPCTRA Funding Opportunity Title: DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award Opportunity Category: Discretionary Opportunity Category Explanation: Funding Instrument Type: Grant Category of Funding Activity: Science and Technology and other Research and Development Category Explanation: Expected Number of Awards: 6 Assistance Listings: 12.420 -- Military Medical Research and Development Cost Sharing or Matching Requirement: No Version: Synopsis 2 Posted Date: Jun 17, 2026 Last Updated Date: Jun 24, 2026 Original Closing Date for Applications: Sep 18, 2026 Current Closing Date for Applications: Sep 18, 2026 Archive Date: Oct 18, 2026 Estimated Total Program Funding: $ 8,460,000 Award Ceiling: $ Award Floor: $ Eligibility Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: Additional Information Agency Name: Defense Health Agency Contracting Activity - DHACA Description: Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged. Distinctive Features: The FY26 CTRA offers two funding levels: Funding Level 1 to support smaller, less complex preclinical and/or clinical research. Funding Level 2 to support larger, more complex preclinical and/or clinical research. The FY26 CTRA Also Offers a Partnering PI Option (PPIO) To Support Meaningful And Productive Partnerships Between Two Investigators Collaborating On The Proposed Research Project. The PPIO Has Two Eligibility Categories Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission. Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed. Link to Additional Information: Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact: eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org eBRAP Help Desk